Mid-America Apartment Communities, Inc. News Headlines

MAA 
$75.93
*  
0.07
0.09%
Get MAA Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading MAA now
Exchange: NYSE
Industry: Consumer Services
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Healthcare REITs Risk Report: Caution Merited
12/24/2014 4:01:00 PM - Seeking Alpha


Insiders Were Right: MAA Makes New 52-Week High
12/22/2014 1:45:30 PM - BNK Invest


With Insiders Likely Itching For Profits, Short Opportunity Ahead For Radius Health Investors
12/2/2014 10:30:00 AM - Seeking Alpha


Mid-America Apartment Communities (MAA) Passes Through 4% Yield Mark
12/1/2014 3:31:17 PM - BNK Invest


Dividend Challengers (And Near-Challengers): 44 Increase Expected By January 31
11/17/2014 4:57:00 AM - Seeking Alpha


Will Intercept Pharmaceuticals' (ICPT) Q3 Loss Narrow? - Analyst Blog
11/6/2014 4:02:00 PM - Zacks.com


Mid-America Apartment Communities Q3 14 Earnings Conference Call At 10:00 AM ET
10/30/2014 9:08:00 AM - RTT News


Mid-America Apartment Q3 FFO Rises, Tops View; Lifts FY Outlook
10/29/2014 6:21:00 PM - RTT News


Vertex Pharmaceuticals (VRTX) Updates on Kalydeco Studies - Analyst Blog
10/10/2014 4:43:00 PM - Zacks.com


Mid-America Apartment Communities, Inc. (MAA) Ex-Dividend Date Scheduled for October 10, 2014
10/9/2014 8:00:02 AM - NASDAQ.com News


Amgen Seeks EU Approval for PCSK9 Inhibitor Evolocumab - Analyst Blog
9/4/2014 5:00:00 PM - Zacks.com


REIT Valuation Part 3: Residential
8/28/2014 2:30:00 AM - Seeking Alpha


Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog
8/25/2014 5:25:00 PM - Zacks.com


Astellas-Basilea's Isavuconazole Accepted for EU Review - Analyst Blog
8/21/2014 4:30:00 PM - Zacks.com


UDR Poised to Ride High with Focus on Strategic Priorities - Analyst Blog
7/22/2014 5:45:00 PM - Zacks.com


Sunesis' Pediatric Plan Accepted in the EU - Analyst Blog
7/14/2014 5:45:00 PM - Zacks.com


Hyperion's Ravicti Submission Accepted in EU - Analyst Blog
6/26/2014 4:20:00 PM - Zacks.com


MAA Breaks Above 4% Yield Territory
6/6/2014 2:09:07 PM - BNK Invest


Vanda Up on EU News - Analyst Blog
6/5/2014 6:01:00 PM - Zacks.com


Pipeline Progress at RedHill Biopharma - Analyst Blog
5/23/2014 5:00:00 PM - Zacks.com


Dynavax Reports In Line Q1 Results - Analyst Blog
5/6/2014 10:50:01 AM - Zacks.com


Synageva's Q1 Loss Narrower than Expected - Analyst Blog
5/1/2014 4:10:01 PM - Zacks.com


Unplanned Early Retirement, Part 3 - REITs In My IRA
4/29/2014 2:04:00 PM - Seeking Alpha


Regulatory Update from Impax - Analyst Blog
4/15/2014 3:55:01 PM - Zacks.com


Mid-America Apartment Communities, Inc. (MAA) Ex-Dividend Date Scheduled for April 11, 2014
4/10/2014 8:00:01 AM - NASDAQ.com News